CXCL5 and central nervous system cancer: The original RNA-seq results suggested that glioma patients have higher levels of CCL20, CXCL1, CXCL2, CXCL5, and CXCL16 compared to noncancerous patients and that the levels of these small chemotactic cytokines in glioma are correlated with malignancy.